Special collections

A new, less invasive approach for retroperitoneal pelvic and para-aortic lymphadenectomy combining the transvaginal natural orifice transluminal endoscopic surgery (vNOTES) technique and single-port laparoscopy
Behzat Can, Sedat Akgöl, Özgür Adıgüzel, Cihan Kaya

International Journal of Gynecologic Cancer May 2024, 34 (5) 789-790; DOI: 10.1136/ijgc-2023-005093
Molecular profile is a strong predictor of the pattern of recurrence in patients with endometrial cancer
Ana Luzarraga Aznar, Vicente Bebia, Carlos López-Gil, Beatriz Villafranca-Magdalena, Lourdes Salazar-Huayna, Josep Castellvi, Eva Colàs, Antonio Gil-Moreno, Silvia Cabrera

International Journal of Gynecologic Cancer May 2024, 34 (5) 659-666; DOI: 10.1136/ijgc-2023-005165
Primary chemoradiation versus neoadjuvant chemotherapy followed by surgery as treatment strategy for locally advanced vulvar carcinoma (VULCANize2)
Frédéric Amant, Anne Fleur van Velzen, An Reyners, Henry Zijlmans, Eva E Schaake, Linda Nooij

International Journal of Gynecologic Cancer May 2024, ijgc-2024-005493; DOI: 10.1136/ijgc-2024-005493
Mirvetuximab soravtansine-gynx: first antibody/antigen-drug conjugate (ADC) in advanced or recurrent ovarian cancer
Giorgio Bogani, Robert L Coleman, Ignace Vergote, Toon van Gorp, Isabelle Ray-Coquard, Ana Oaknin, Ursula Matulonis, David O’Malley, Francesco Raspagliesi, Giovanni Scambia, Bradley J Monk

International Journal of Gynecologic Cancer Apr 2024, 34 (4) 469-477; DOI: 10.1136/ijgc-2023-004924
Intrauterine manipulator use during laparoscopic hysterectomy for endometrial cancer: association for pathological factors and oncologic outcomes
Hiroshi Yoshida, Koji Matsuo, Hiroko Machida, Shinya Matsuzaki, Michihide Maeda, Yoshito Terai, Takuma Fujii, Masaki Mandai, Kei Kawana, Hiroaki Kobayashi, Mikio Mikami, Satoru Nagase

International Journal of Gynecologic Cancer Apr 2024, 34 (4) 510-518; DOI: 10.1136/ijgc-2023-005102
Recurrence rates and patterns of recurrence in stage IA p53abn endometrial cancer with and without myometrial invasion
Amy Jamieson, Marcel Grube, Samuel Leung, Derek Chiu, Amy Lum, Janice S Kwon, Aline Talhouk, Blake Gilks, Stefan Kommoss, Jessica N McAlpine

International Journal of Gynecologic Cancer Apr 2024, 34 (4) 544-549; DOI: 10.1136/ijgc-2023-005149
Updated progression-free survival and final overall survival with maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial
Domenica Lorusso, Marie-Ange Mouret-Reynier, Philipp Harter, Claire Cropet, Cristina Caballero, Pia Wolfrum-Ristau, Toyomi Satoh, Ignace Vergote, Gabriella Parma, Trine J Nøttrup, Coriolan Lebreton, Peter A Fasching, Carmela Pisano, Luis Manso, Hugues Bourgeois, Ingo Runnebaum, Claudio Zamagni, Anne-Claire Hardy-Bessard, Andreas Schnelzer, Michel Fabbro, Barbara Schmalfeldt, Dominique Berton, Antje Belau, Jean-Pierre Lotz, Martina Gropp-Meier, Laurence Gladieff, Hans-Joachim Lück, Sophie Abadie-Lacourtoisie, Eric Pujade-Lauraine, Isabelle Ray-Coquard

International Journal of Gynecologic Cancer Apr 2024, 34 (4) 550-558; DOI: 10.1136/ijgc-2023-004995
Phase I study of ombrabulin in combination with paclitaxel and carboplatin in Japanese patients with advanced solid tumors
Koji Matsumoto, Yoshinori Sunaga, Evelyne Ecstein-Fraisse, Keiichi Fujiwara

International Journal of Gynecologic Cancer Apr 2024, 34 (4) 586-593; DOI: 10.1136/ijgc-2022-003880
Procedural interventions for oligoprogression during treatment with immune checkpoint blockade in gynecologic malignancies: a case series
Tiffany Y Sia, Vivian Wan, Michael Finlan, Qin C Zhou, Alexia Iasonos, Oliver Zivanovic, Yukio Sonoda, Dennis S Chi, Kara Long Roche, Elizabeth Jewell, William P Tew, Roisin E O'Cearbhaill, Seth Cohen, Vicky Makker, Ying L Liu, Claire F Friedman, Chrisann Kyi, Dmitriy Zamarin, Ginger Gardner

International Journal of Gynecologic Cancer Apr 2024, 34 (4) 594-601; DOI: 10.1136/ijgc-2023-004842
A phase II, multicenter, open-label study of abemaciclib and letrozole in patients with estrogen receptor-positive rare ovarian cancer: ALEPRO trial
Tine Ottenbourgs, Toon van Gorp, Frédéric Kridelka, Thaïs Baert, Hannelore Denys, Frédéric Selle, Inge Baas, Anne-Sophie Van Rompuy, Diether Lambrechts, Els Van Nieuwenhuysen

International Journal of Gynecologic Cancer Apr 2024, 34 (4) 627-630; DOI: 10.1136/ijgc-2023-005189

Main menu

Special collections

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Special collections

Pages